{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:26:21Z","timestamp":1787826381280,"version":"build-2784847793"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Salivary gland cancers are rare, diverse malignancies characterized by poor response to immunotherapy. The tumor immune environment in these cancers remains poorly understood. To address this, we perform an integrative analysis of the tumor immune microenvironment in a large cohort of advanced salivary gland cancer samples. Most tumors exhibit low immune activity with limited immune cell infiltration. Inflammation is linked to higher tumor mutational burden in non-adenoid cystic carcinoma histologies. Subtype specific expression of immune checkpoints is identified with prominent expression of <jats:italic>VTCN1<\/jats:italic> in luminal-like cells within adenoid cystic carcinoma. Macrophages with immunosuppressive properties dominate the immune microenvironment across subtypes. Responses to immunotherapy are limited and associated with a higher ratio of T-cells relative to macrophages in individual cases, warranting further investigation. Here, we show an immunosuppressive environment in salivary gland cancers and identify subtype-specific immune vulnerabilities that could inform tailored therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s41467-025-60421-0","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T09:35:45Z","timestamp":1749720945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Erika","family":"Zuljan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"von der Emde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Piwonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Pestana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Klinghammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3332-9166","authenticated-orcid":false,"given":"Andreas","family":"Mock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4536-9306","authenticated-orcid":false,"given":"Peter","family":"Horak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Heining","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9131-2389","authenticated-orcid":false,"given":"Frederick","family":"Klauschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Pretzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3670-0602","authenticated-orcid":false,"given":"Melanie","family":"Boerries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian H.","family":"Brandts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3278-4586","authenticated-orcid":false,"given":"Simon","family":"Kreutzfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Veronica","family":"Teleanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6041-7049","authenticated-orcid":false,"given":"Daniel","family":"H\u00fcbschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4417-2280","authenticated-orcid":false,"given":"Luc G. T.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4987-2913","authenticated-orcid":false,"given":"Max","family":"Heiland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8485-1958","authenticated-orcid":false,"given":"Ulrich","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5618-6295","authenticated-orcid":false,"given":"Thomas","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4104-1135","authenticated-orcid":false,"given":"Hanno","family":"Glimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7907-4595","authenticated-orcid":false,"given":"Stefan","family":"Fr\u00f6hling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6024-4312","authenticated-orcid":false,"given":"Sebastian","family":"Ochsenreither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Keilholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Beule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0027-7977","authenticated-orcid":false,"given":"Damian T.","family":"Rieke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"60421_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12105-022-01420-1","volume":"16","author":"A Sk\u00e1lov\u00e1","year":"2022","unstructured":"Sk\u00e1lov\u00e1, A., Hyrcza, M. D. & Leivo, I. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands. Head. Neck Pathol. 16, 40\u201353 (2022).","journal-title":"Head. Neck Pathol."},{"key":"60421_CR2","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1245\/s10434-016-5356-3","volume":"23","author":"SJ Nam","year":"2016","unstructured":"Nam, S. J. et al. Risk factors and survival associated with distant metastasis in patients with carcinoma of the salivary gland. Ann. Surg. Oncol. 23, 4376\u20134383 (2016).","journal-title":"Ann. Surg. Oncol."},{"key":"60421_CR3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/hed.23925","volume":"38","author":"PM Dillon","year":"2016","unstructured":"Dillon, P. M., Chakraborty, S., Moskaluk, C. A., Joshi, P. J. & Thomas, C. Y. Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials. Head. Neck 38, 620\u2013627 (2016).","journal-title":"Head. Neck"},{"key":"60421_CR4","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/1078-0432.CCR-20-1192","volume":"27","author":"R Ferrarotto","year":"2023","unstructured":"Ferrarotto, R. et al. Proteogenomic analysis of salivary adenoid cystic carcinomas defines molecular subtypes and identifies therapeutic targets. Clin. Cancer Res. 27, 852\u2013864 (2023).","journal-title":"Clin. Cancer Res."},{"key":"60421_CR5","doi-asserted-by":"publisher","first-page":"100602","DOI":"10.1016\/j.esmoop.2022.100602","volume":"7","author":"C Van Herpen","year":"2022","unstructured":"Van Herpen, C. et al. Salivary gland cancer: ESMO\u2013European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open 7, 100602 (2022).","journal-title":"ESMO Open"},{"key":"60421_CR6","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/COC.0000000000000429","volume":"41","author":"RB Cohen","year":"2018","unstructured":"Cohen, R. B. et al. Pembrolizumab for the treatment of advanced salivary gland carcinoma: findings of the phase 1b KEYNOTE-028 Study. Am. J. Clin. Oncol. 41, 1083\u20131088 (2018).","journal-title":"Am. J. Clin. Oncol."},{"key":"60421_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ejca.2022.05.007","volume":"171","author":"C Even","year":"2022","unstructured":"Even, C. et al. Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study. Eur. J. Cancer 171, 259\u2013268 (2022).","journal-title":"Eur. J. Cancer"},{"key":"60421_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73965-6","volume":"10","author":"K Niwa","year":"2020","unstructured":"Niwa, K. et al. Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma. Sci. Rep. 10, 16988 (2020).","journal-title":"Sci. Rep."},{"key":"60421_CR9","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1038\/s41591-023-02518-x","volume":"29","author":"JL Vos","year":"2023","unstructured":"Vos, J. L. et al. Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial. Nat. Med. 29, 3077\u20133089 (2023).","journal-title":"Nat. Med."},{"key":"60421_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ijrobp.2020.08.018","volume":"109","author":"U Mahmood","year":"2021","unstructured":"Mahmood, U. et al. A randomized Phase 2 study of Pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma. Int. J. Radiat. Oncol. 109, 134\u2013144 (2021).","journal-title":"Int. J. Radiat. Oncol."},{"key":"60421_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1158\/1078-0432.CCR-19-2214","volume":"26","author":"CP Rodriguez","year":"2020","unstructured":"Rodriguez, C. P. et al. A Phase II trial of Pembrolizumab and Vorinostat in recurrent metastatic head and neck squamous cell carcinomas and salivary gland cancer. Clin. Cancer Res. 26, 837\u2013845 (2020).","journal-title":"Clin. Cancer Res."},{"key":"60421_CR12","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.21.00449","volume":"39","author":"JL Geiger","year":"2021","unstructured":"Geiger, J. L. et al. Management of salivary gland malignancy: ASCO Guideline. J. Clin. Oncol. 39, 1909\u20131941 (2021).","journal-title":"J. Clin. Oncol."},{"key":"60421_CR13","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1158\/1078-0432.CCR-19-3758","volume":"26","author":"M Linxweiler","year":"2020","unstructured":"Linxweiler, M. et al. The immune microenvironment and neoantigen landscape of aggressive salivary gland carcinomas differ by subtype. Clin. Cancer Res. 26, 2859\u20132870 (2020).","journal-title":"Clin. Cancer Res."},{"key":"60421_CR14","doi-asserted-by":"publisher","first-page":"618367","DOI":"10.3389\/fimmu.2021.618367","volume":"12","author":"S Dou","year":"2021","unstructured":"Dou, S. et al. The immune landscape of Chinese head and neck adenoid cystic carcinoma and clinical implication. Front. Immunol. 12, 618367 (2021).","journal-title":"Front. Immunol."},{"key":"60421_CR15","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1158\/1078-0432.CCR-23-0514","volume":"29","author":"LG Sousa","year":"2023","unstructured":"Sousa, L. G. et al. Spatial immunoprofiling of adenoid cystic carcinoma reveals B7-H4 is a therapeutic target for aggressive tumors. Clin. Cancer Res. 29, 3162\u20133171 (2023).","journal-title":"Clin. Cancer Res."},{"key":"60421_CR16","doi-asserted-by":"publisher","first-page":"103745","DOI":"10.1016\/j.critrevonc.2022.103745","volume":"176","author":"VP Wagner","year":"2022","unstructured":"Wagner, V. P., Bingle, C. D. & Bingle, L. MYB-NFIB fusion transcript in adenoid cystic carcinoma: Current state of knowledge and future directions. Crit. Rev. Oncol. Hematol. 176, 103745 (2022).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"60421_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature23477","volume":"548","author":"SJ Patel","year":"2017","unstructured":"Patel, S. J. et al. Identification of essential genes for cancer immunotherapy. Nature 548, 537\u2013542 (2017).","journal-title":"Nature"},{"key":"60421_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04355-w","volume":"9","author":"A Porrello","year":"2018","unstructured":"Porrello, A. et al. Factor XIIIA\u2014expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking. Nat. Commun. 9, 1988 (2018).","journal-title":"Nat. Commun."},{"key":"60421_CR19","doi-asserted-by":"publisher","first-page":"iqad006","DOI":"10.1093\/oxfimm\/iqad006","volume":"4","author":"E Jenkins","year":"2023","unstructured":"Jenkins, E., Whitehead, T., Fellermeyer, M., Davis, S. J. & Sharma, S. The current state and future of T-cell exhaustion research. Oxf. Open Immunol. 4, iqad006 (2023).","journal-title":"Oxf. Open Immunol."},{"key":"60421_CR20","doi-asserted-by":"publisher","first-page":"108402","DOI":"10.1016\/j.celrep.2020.108402","volume":"33","author":"M Saitou","year":"2020","unstructured":"Saitou, M. et al. Functional specialization of human salivary glands and origins of proteins intrinsic to human saliva. Cell Rep. 33, 108402 (2020).","journal-title":"Cell Rep."},{"key":"60421_CR21","doi-asserted-by":"publisher","first-page":"606268","DOI":"10.3389\/fimmu.2020.606268","volume":"11","author":"A Oyelakin","year":"2021","unstructured":"Oyelakin, A. et al. Transcriptomic and network analysis of minor salivary glands of patients with primary Sj\u00f6gren\u2019s Syndrome. Front. Immunol. 11, 606268 (2021).","journal-title":"Front. Immunol."},{"key":"60421_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/00220345221147908","volume":"102","author":"E Horeth","year":"2023","unstructured":"Horeth, E. et al. High-resolution transcriptomic landscape of the human submandibular gland. J. Dent. Res. 102, 525\u2013535 (2023).","journal-title":"J. Dent. Res."},{"key":"60421_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00501-4","volume":"8","author":"J Hong","year":"2024","unstructured":"Hong, J. et al. Immunological subtyping of salivary gland cancer identifies histological origin-specific tumor immune microenvironment. Npj Precis. Oncol. 8, 15 (2024).","journal-title":"Npj Precis. Oncol."},{"key":"60421_CR24","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1001\/archotol.129.11.1193","volume":"129","author":"M-W Sung","year":"2003","unstructured":"Sung, M.-W. et al. Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck. Arch. Otolaryngol. Neck Surg. 129, 1193 (2003).","journal-title":"Arch. Otolaryngol. Neck Surg."},{"key":"60421_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369\u2013382 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"60421_CR26","doi-asserted-by":"publisher","first-page":"e126908","DOI":"10.1172\/jci.insight.126908","volume":"4","author":"M Yarchoan","year":"2019","unstructured":"Yarchoan, M. et al. PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers. JCI Insight 4, e126908 (2019).","journal-title":"JCI Insight"},{"key":"60421_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.immuni.2018.03.018","volume":"48","author":"J Li","year":"2018","unstructured":"Li, J. et al. Co-inhibitory molecule B7 Superfamily Member 1 Expressed by tumor-infiltrating myeloid cells induces dysfunction of anti-tumor CD8+T Cells. Immunity 48, 773\u2013786.e5 (2018).","journal-title":"Immunity"},{"key":"60421_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-018-0095-1","volume":"4","author":"M Altan","year":"2018","unstructured":"Altan, M. et al. Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer. Npj Breast Cancer 4, 40 (2018).","journal-title":"Npj Breast Cancer"},{"key":"60421_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/his.13226","volume":"71","author":"S Beppu","year":"2017","unstructured":"Beppu, S. et al. Expression of cancer\/testis antigens in salivary gland carcinomas with reference to MAGE \u2010A and NY \u2010 ESO \u20101 expression in adenoid cystic carcinoma. Histopathology 71, 305\u2013315 (2017).","journal-title":"Histopathology"},{"key":"60421_CR30","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1158\/2159-8290.CD-21-0126","volume":"11","author":"P Horak","year":"2021","unstructured":"Horak, P. et al. Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers. Cancer Discov. 11, 2780\u20132795 (2021).","journal-title":"Cancer Discov."},{"key":"60421_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"60421_CR32","doi-asserted-by":"publisher","unstructured":"Benjamin, D. et al. Calling Somatic SNVs and Indels with Mutect2. http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/861054 (2019) https:\/\/doi.org\/10.1101\/861054.","DOI":"10.1101\/861054"},{"key":"60421_CR33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1101\/gr.257246.119","volume":"31","author":"S Uhrig","year":"2021","unstructured":"Uhrig, S. et al. Accurate and efficient detection of gene fusions from RNA sequencing data. Genome Res 31, 448\u2013460 (2021).","journal-title":"Genome Res"},{"key":"60421_CR34","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.1073\/pnas.1009843107","volume":"107","author":"P Van Loo","year":"2010","unstructured":"Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. 107, 16910\u201316915 (2010).","journal-title":"Proc. Natl Acad. Sci."},{"key":"60421_CR35","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1093\/bioinformatics\/btz447","volume":"35","author":"J Zyla","year":"2019","unstructured":"Zyla, J. et al. Gene set enrichment for reproducible science: comparison of CERNO and eight other algorithms. Bioinformatics 35, 5146\u20135154 (2019).","journal-title":"Bioinformatics"},{"key":"60421_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinforma. 14, 7 (2013).","journal-title":"BMC Bioinforma."},{"key":"60421_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","volume":"5","author":"P Danaher","year":"2017","unstructured":"Danaher, P. et al. Gene expression markers of Tumor Infiltrating Leukocytes. J. Immunother. Cancer 5, 18 (2017).","journal-title":"J. Immunother. Cancer"},{"key":"60421_CR38","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers, M. et al. IFN-\u03b3\u2013related mRNA profile predicts clinical response to PD-1 blockade. J. Clin. Invest. 127, 2930\u20132940 (2017).","journal-title":"J. Clin. Invest."},{"key":"60421_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1092-z","volume":"17","author":"Y \u015eenbabao\u011flu","year":"2016","unstructured":"\u015eenbabao\u011flu, Y. et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 17, 231 (2016).","journal-title":"Genome Biol."},{"key":"60421_CR40","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782\u2013795 (2013).","journal-title":"Immunity"},{"key":"60421_CR41","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s41591-023-02324-5","volume":"29","author":"J Roelands","year":"2023","unstructured":"Roelands, J. et al. An integrated tumor, immune and microbiome atlas of colon cancer. Nat. Med. 29, 1273\u20131286 (2023).","journal-title":"Nat. Med."},{"key":"60421_CR42","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.21873\/anticanres.13030","volume":"38","author":"H Wakiyama","year":"2018","unstructured":"Wakiyama, H. et al. Cytolytic Activity (CYT) score is a prognostic biomarker reflecting host immune status in Hepatocellular Carcinoma (HCC). Anticancer Res 38, 6631\u20136638 (2018).","journal-title":"Anticancer Res"},{"key":"60421_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"60421_CR44","doi-asserted-by":"crossref","unstructured":"Chen, B., Khodadoust, M. S., Liu, C. L., Newman, A. M. & Alizadeh, A. A. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. in Cancer Systems Biology (ed. Von Stechow, L.) vol. 1711 243\u2013259 (Springer New York, New York, NY, 2018).","DOI":"10.1007\/978-1-4939-7493-1_12"},{"key":"60421_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017).","journal-title":"Genome Biol."},{"key":"60421_CR46","doi-asserted-by":"crossref","unstructured":"Sturm, G., Finotello, F. & List, M. Immunedeconv: An R Package for Unified Access to Computational Methods for Estimating Immune Cell Fractions from Bulk RNA-Sequencing Data. in Bioinformatics for Cancer Immunotherapy (ed. Boegel, S.) vol. 2120 223\u2013232 (Springer US, New York, NY, 2020).","DOI":"10.1007\/978-1-0716-0327-7_16"},{"key":"60421_CR47","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/modpathol.2013.54","volume":"26","author":"R Ohtomo","year":"2013","unstructured":"Ohtomo, R. et al. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis. Mod. Pathol. 26, 1041\u20131050 (2013).","journal-title":"Mod. Pathol."},{"key":"60421_CR48","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D.-C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28, 1747\u20131756 (2018).","journal-title":"Genome Res"},{"key":"60421_CR49","doi-asserted-by":"publisher","first-page":"580141","DOI":"10.3389\/fonc.2020.580141","volume":"10","author":"L Di Villeneuve","year":"2020","unstructured":"Di Villeneuve, L., Souza, I. L., Tolentino, F. D. S., Ferrarotto, R. & Schvartsman, G. Salivary gland carcinoma: novel targets to overcome treatment resistance in advanced disease. Front. Oncol. 10, 580141 (2020).","journal-title":"Front. Oncol."},{"key":"60421_CR50","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41588-024-01659-0","volume":"56","author":"H Jin","year":"2024","unstructured":"Jin, H. et al. Accurate and sensitive mutational signature analysis with MuSiCal. Nat. Genet. 56, 541\u2013552 (2024).","journal-title":"Nat. Genet."},{"key":"60421_CR51","doi-asserted-by":"publisher","first-page":"D1210","DOI":"10.1093\/nar\/gkad986","volume":"52","author":"Z Sondka","year":"2024","unstructured":"Sondka, Z. et al. COSMIC: a curated database of somatic variants and clinical data for cancer. Nucleic Acids Res. 52, D1210\u2013D1217 (2024).","journal-title":"Nucleic Acids Res."},{"key":"60421_CR52","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/s41592-023-01943-7","volume":"20","author":"SJ Fleming","year":"2023","unstructured":"Fleming, S. J. et al. Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender. Nat. Methods 20, 1323\u20131335 (2023).","journal-title":"Nat. Methods"},{"key":"60421_CR53","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.2","volume":"10","author":"P-L Germain","year":"2022","unstructured":"Germain, P.-L., Lun, A., Garcia Meixide, C., Macnair, W. & Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Research 10, 979 (2022).","journal-title":"F1000Research"},{"key":"60421_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0947-7","volume":"17","author":"AT Lun","year":"2016","unstructured":"Lun, A. T., Bach, K. & Marioni, J. C. Pooling across cells to normalize single-cell RNA sequencing data with many zero counts. Genome Biol. 17, 75 (2016).","journal-title":"Genome Biol."},{"key":"60421_CR55","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"60421_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41695-z","volume":"9","author":"VA Traag","year":"2019","unstructured":"Traag, V. A., Waltman, L. & Van Eck, N. J. From Louvain to Leiden: guaranteeing well-connected communities. Sci. Rep. 9, 5233 (2019).","journal-title":"Sci. Rep."},{"key":"60421_CR57","doi-asserted-by":"publisher","first-page":"1063477","DOI":"10.3389\/fonc.2022.1063477","volume":"12","author":"Q Lin","year":"2022","unstructured":"Lin, Q. et al. Single-cell transcriptomic analysis of the tumor ecosystem of adenoid cystic carcinoma. Front. Oncol. 12, 1063477 (2022).","journal-title":"Front. Oncol."},{"key":"60421_CR58","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"60421_CR59","doi-asserted-by":"publisher","unstructured":"Xu, C. et al. Automatic Cell Type Harmonization and Integration across Human Cell Atlas Datasets. http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2023.05.01.538994 (2023) https:\/\/doi.org\/10.1101\/2023.05.01.538994.","DOI":"10.1101\/2023.05.01.538994"},{"key":"60421_CR60","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/ijc.35079","volume":"155","author":"T Wei","year":"2024","unstructured":"Wei, T. et al. High\u2010confidence calling of normal epithelial cells allows identification of a novel stem\u2010like cell state in the colorectal cancer microenvironment. Int. J. Cancer 155, 1655\u20131669 (2024).","journal-title":"Int. J. Cancer"},{"key":"60421_CR61","doi-asserted-by":"publisher","first-page":"111743","DOI":"10.1016\/j.celrep.2022.111743","volume":"41","author":"AS Parikh","year":"2022","unstructured":"Parikh, A. S. et al. Single-cell RNA sequencing identifies a paracrine interaction that may drive oncogenic notch signaling in human adenoid cystic carcinoma. Cell Rep. 41, 111743 (2022).","journal-title":"Cell Rep."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60421-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60421-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60421-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T13:05:45Z","timestamp":1749733545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60421-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60421"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60421-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.H. received honoraria, research funding and\/or consulting\/advisory board from Roche, Novartis, and Boehringer Ingelheim. S.F. reports consultancy fees from\u00a0Illumina,\u00a0DTR has received honoraria, research support, and\/or travel\/accommodation expenses from Bayer, Eli Lilly, Bristol-Myers Squibb, Roche, BeiGene, J&J, and Seagen. The remaining authors report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5303"}}